ClinicalTrials.gg
RecruitingNCT07401212GUTLINK4KIDSUpdated Apr 28, 2026

GUTLINK4KIDS Intervention

An interventional study of Prebiotic powder and Placebo in Temperament, Sleep and Cognition, sponsored by University of Reading. Recruiting at 1 site in United Kingdom. Open to participants aged 3 Years to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by University of Reading · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
3 Years to 5 Years
Sex
All
01

Study summary

This study aims to investigate the chronic effects of prebiotic consumption on cognitive, behavioural and gut microbiome outcomes in children aged 3-5 years.

Read the detailed description

This study will employ a double-blind, randomised, placebo-controlled parallel design to investigate the chronic effects of 8-week-long prebiotic consumption on cognitive, behavioural, and gut microbiome, outcomes in 3-5-year-old children with insufficient fibre intake (less than the average 10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds). One hundred and six participants will be randomised to Intervention or Placebo groups where they will be consuming 5g of prebiotic fibre or 5g of placebo (matched placebo powder) per day for 8-weeks. Outcome measures will be acquired before and after a 8-week chronic supplementation. These will include cognitive and behavioural outcomes of the parents and children. In addition, stool samples will be collected at the baseline and at week 8 to assess microbiome diversity and composition. Additionally, after 4-weeks of wash-out, at 12 weeks, parents will be asked to completed online questionnaires assessing cognitive and behavioural outcome of their children.

02

Conditions studied

  • Temperament
  • Sleep
  • Cognition
  • Emotion Regulation

Browse trials for

Keywords

  • prebiotics
  • emotion regulation
  • gut microbiome diversity
  • children
  • relative abundance
  • sleep
  • internalising symptoms
  • externalising symptoms
03

In context

Emotional Regulation

545 studies on the registry are indexed under Emotional Regulation; 188 are open to participants now.

This study's planned enrollment of 106 is above the median of 79 across 498 interventional studies indexed under Emotional Regulation.

Browse Emotional Regulation studies →

Lead sponsor

University of Reading is the lead sponsor of 150 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parents (18 years and over) of generally healthy children aged 3-5-years-old (36-71 months) with lower dietary fibre intake than the recommended daily amount (10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds).

Exclusion criteria

Exclusion Criteria:

  • Children with a significant acute or chronic co-existing illness (including inflammatory bowel disease, functional gastrointestinal disorders, coeliac disease etc, neurodevelopmental, immunological, psychiatric, or metabolic disorders.
  • Children who have taken any pre/probiotic supplements or antibiotic treatment within the 4 weeks prior to enrolment.
  • Children with food allergies and intolerances
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
106 participants (estimated)

Study arms

  • Experimental
    Prebiotic (powder)

    Children will consume two (one in the morning and one in the evening) 2.5g of prebiotic sachets a day (mixed with food and drink).

    Dietary Supplement: Prebiotic powder

  • Placebo comparator
    Matched placebo (powder)

    Children will consume two (one in the morning and one in the evening) 2.5g of placebo sachets a day (mixed with food and drink).

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementPrebiotic powder

    5g of prebiotic fibre

  • Dietary supplementPlacebo

    5g of placebo

06

What researchers measure

Primary outcomes

  1. Child Behaviour Checklist Ages 1.5-5

    Parents will be asked to complete this validated measure that includes 100 items that assesses a child's emotional, behavioral, and social problems.

    Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)

Secondary outcomes

  1. Emotion Regulation Skills Questionnaire

    Parents will be asked to complete this measure that includes 52 items that assesses a child's adaptive and maladaptive emotion regulation skills.

    Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)

  2. Childhood Autism Spectrum Test

    Parents will be asked to complete this measure that includes 44 items that assesses a child's developmental differences in social and communication functioning

    Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)

  3. Bristol Stool Chart

    Parents will be asked to complete this measure that includes 1 item that assesses a child's stool consistency.

    Time frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)

  4. Gut microbiome diversity

    Children's stool samples will be collected to measure gut microbiome diversity. Indices of alpha and beta diversity will be analysed (16s sequencing).

    Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

  5. Gut microbiome composition

    Children's stool samples will be collected to measure gut microbiome composition (genus and species) (16s sequencing).

    Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

Other outcomes

  1. Attentional Control Scale

    Parents will be asked to complete this measure that includes 20 items that assesses their own attentional control.

    Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

  2. Difficulties in Emotional Regulation Scale

    Parents will be asked to complete this measure that includes 36 items that assesses their own emotion regulation skills.

    Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

  3. Patient Health Questionnaire-8

    Parents will be asked to complete this measure that includes 8 items that assesses their own depressed mood.

    Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

  4. Generalised Anxiety Disorder-7

    Parents will be asked to complete this measure that includes 7 items that assesses their own anxious mood.

    Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

  5. Child-Parent Relationship Scale

    Parents will be asked to complete this measure that includes 30 items that assesses their relationship with their child/children.

    Time frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).

  6. Scottish Collaborative Group Child VC2 Food Frequency Questionnaire

    Parents will be asked to complete this measure that assesses their child's habitual food intake.

    Time frame: This measure will be taken at baseline (pre intervention).

  7. Child Eating Behaviour Questionnaire

    Parents will be asked to complete this measure that assesses their child's eating behaviour.

    Time frame: This measure will be taken at baseline (pre intervention).

  8. Dietary recall

    This measure will be used to screen participants. Parents will be asked to complete this measure that assesses their child's food intake. Children with insufficient fibre intake (less than the average 10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds) will be eligible for the study.

    Time frame: This measure will be taken during screening and at week 8 (post intervention).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07401212
Collaborators
Beneo GmbH
Responsible party
Piril Hepsomali (Principle Investigator, University of Reading) — Principal investigator
First posted
Feb 10, 2026
Start date
Mar 2, 2026
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Apr 28, 2026

Study contacts

Piril Hepsomali, PhD
Contact
p.hepsomali@reading.ac.uk
+44 118 378 5818

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Prebiotics

Start the discussion